Trials / Completed
CompletedNCT00605631
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the effect of pacing on post-MI patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cardiac pacing using any Guidant/Boston Scientific Implantable ICD or CRT-D System and any Guidant/Boston Scientific Intracardiac Lead System | No specific device model is required - any FDA-approved, market-released Guidant/Boston Scientific implantable ICD or CRT-D system and any FDA-approved, market-released Guidant/Boston Scientific intracardiac lead system may be implanted as part of MENDMI. |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2008-01-31
- Last updated
- 2017-04-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00605631. Inclusion in this directory is not an endorsement.